|||
Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure)
Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen
radionuclidetherapie van metastase in bot bij prostaatcarcinoom met Lu177 - PSMA
radionuclidetherapie van botmetastasen bij prostaatcarcinoom met Lu177 - PSMA
Id97371000146109
StatusPrimitive
Direct morphologyNeoplasm, metastatic
MethodRadioactive destruction
Using substanceLutetium-177
Has intentTherapeutic
Using energyRadiation
DHD Procedure thesaurus reference set